hero-654791312-sized

Ensights

Science that is transforming lives and enabling the future

Four Important Things to Validate in Your Freeze/Thaw Workflow

All Posts

Four Important Things to Validate in Your Freeze/Thaw Workflow

The impact of the freeze/thaw process on workflows requires it be treated as a unit operation of its own.

Based on current trends, 30 of the top 50 global biopharma products will require cold chain handling resulting from more complex therapeutics, scale-up of biosimilars, expanding distribution range, regulatory increases, and pandemic-targeted therapies. Ensuring your freeze/thaw workflow is validated along the way is critical in the safe delivery and distribution of sensitive products, as well as time, expense, and patient considerations. Protect, fill, freeze, store, ship, thaw, and drain; there are many opportunities for failures to happen along the process workflow.
A cracked bag can cause contamination. Warm temperatures during shipping could compromise drug proteins. Getting it right during validation ensures that the product can be delivered to patients the way it was intended.

Ensuring the safety, purity, and efficacy of biopharma products continues to be at
the forefront of drug manufacturers’ development and delivery process. Complex therapeutics coupled with multifaceted global logistics require validation throughout the drug manufacturing journey. For long-term product stability and decoupled manufacturing flexibility, freeze/thaw workflows are employed. Here, not only is storage temperature important, but container integrity and rates of freezing and thawing can compromise drug proteins. Customers need a controlled, consistent, and scalable cold chain workflow where product materials are stored, handled, or transported in a manner that mitigates risk for breakage, contamination, and expensive product loss.

Four important considerations to validate in your freeze/thaw workflow. How do you validate these? What are the pitfalls?

1. Primary Container

  • Understanding the impact from all fluid contact surfaces on the biological product. Characterizing the product’s sensitivities (pH, UV light, adsorption, etc.) and validating primary contact materials that ensure product purity and stability during storage and transport.  

2. Freeze/Thaw Process

  • Developing and validating a repeatable freeze and thaw process that enables maximum product recovery. Utilizing a cooling and warming rate that reduces cryoconcentration, aggregation, denaturation, or other undesirable changes to the product’s critical quality attributes.

3. Scalable Freeze/Thaw Equipment

  • The freeze/thaw process should utilize scalable equipment that can be validated at the initial lab/feasibility scale all the way up to production/commercial scale. Identification and sourcing of new equipment
    or utilization of existing infrastructure will guide the validation approach.

4. Shipping/Distribution Lane

  • Shipping containers and related packaging materials must be validated in both thermal and mechanical transportation environments that best represent the expected distribution lane. This reduces the risk of container breakage or contamination as well as temperature excursions that compromise product integrity.

As a trusted partner provider of single-use solutions for bulk freeze/thaw storage
and transport, we understand unique customer needs. By delivering customized solutions backed by a global infrastructure, customers receive beneficial outcomes.

Our world-class Life Sciences Technology Center is dedicated to offering customers access to experts who, with their deep knowledge of testing, equipment, and containment, will guide you through freeze/thaw process optimization strategies.

Learn more about how we can help.

Related Posts

Designing for Extended Performance in Life Science Contaminant Removal

Designing for Extended Performance in Life Science Contaminant Removal Filters have a finite lifetime, and their performance also changes over time. How do you get the most performance over the longest lifespan?

Entegris Offers New FOUP Form-Factors for Non-Standard Wafers

Entegris Offers New FOUP Form-Factors for Non-Standard Wafers Over the last few years, 3D stacking has gone from a relatively niche fabrication method to an absolute necessity for cutting-edge applications. As chipmakers delve into smaller and smaller nodes, stacking and die-bonding wafers has become a preferred way of creating more processing power in a smaller space. Stacked and bonded wafers don’t behave the same way as 2D wafers: Wafers are thinned prior to bonding, which results in wafers that can sag when handled Bonded wafers are thicker and heavier than 2D wafers when assembled Bonded wafers can also warp following assembly Many automation tools rely on the predictable geometry and characteristics of 2D silicon wafers for safe handling and transport. While stacked and bonded wafers are a game-changer for miniaturization, they can also force manufacturing compromises unless chipmakers adopt specialized tools for the back end of the line (BEOL).

A Thermal Stability Study of Phosphoramidites Employed in Oligonucleotide Synthesis

A Thermal Stability Study of Phosphoramidites Employed in Oligonucleotide Synthesis In the dynamic world of drug design, thermal stability plays a crucial role, often determining the success of innovative treatments. As researchers push the boundaries of medicine, the need for robust and effective RNA- and DNA-based drugs has never been greater. This is where the phosphoramidite method of DNA synthesis shines, but understanding the thermal stability of its components, especially phosphoramidites, is essential. In this blog, we will explore why thermal stability is vital in drug development, delve into a study focused on phosphoramidites, and discuss its implications for the field.